Become an IMR Panelist
IMR Logo

Prosthetic Heart Valve Market - Latest Advancement & Future Trends (2024-2032)

Prosthetic Heart Valve Market by Heart Type (Mechanical Heart Valves, Bioprosthetic Heart Valves, Transcatheter Heart Valves), By Valve Type (Aortic Valve, Mitral Valve, Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and Region

  • Report ID : 19636
  • Category : Pharmaceutical and Healthcare
  • Format :Excel formatPDF formatWord format
Request Sample

Prosthetic Heart Valve Market Synopsis:

Prosthetic Heart Valve Market Size Was Valued at USD 10.00 Billion in 2023, and is Projected to Reach USD 29.81 Billion by 2032, Growing at a CAGR of 12.90% From 2024-2032.

The Prosthetic Heart Valve Market means the segment of an economy that deals with the production and distribution of man-made valves to restore the functionality of non-functional human heart valves for valvular heart disease patients. Such prosthetic devices are significant tools in the provision of normal circulation to the heart; hence iproving the life of the patients. The market includes different kinds of valve such as mechanical and bioprosthetic valve that satisfies the various need and demand of the patients.

The Prosthetic Heart Valve Market is mainly spurred due to the ever-rising cases of heart diseases throughout the world. Lack of physical activity, increased number of aging people, and increased obesity rates are some of the reasons for increased frequency of valvular heart diseases. Further, new technologies in the market offer advanced prosthetic heart valves with enhanced durability and fewer complications rates together with minimally invasive surgical options also drive the market.

Furthermore, the rising incidence of inevitable heart valve replacement surgery, driven by higher reimbursement policies coupled with high healthcare care expenses globally, also contributes to market expansion. This is especially because patients are better informed on their possible treatment procedures, and therefore are inclined more to surgical procedures. This trend, together with a growing number of operations for cardiovascular diseases every year, speaks of the growing need for prosthetic heart valves.

Prosthetic Heart Valve Market

Prosthetic Heart Valve Market Trend Analysis:

Increasing adoption of transcatheter aortic valve replacement (TAVR) procedures.

  • Thirdly, the transcatheter aortic valve replacement (TAVR) procedures have also been observed in the Prosthetic Heart Valve Market. This procedure does not involve an opening of the chest or heart; instead, the valves are inserted through a catheter making recovery time and hospital stays considerably shorter than with other valve surgeries. This means that more patients are being recommended for this procedure as more advancements in technology occur, this includes even the high-risk open-heart surgery population thus fueling the market growth of LVADs.

  • Other new directions include using materials advancing science to create bioprosthetic heart valves that increase in the valve performance and durability. Bright ideas at the moment include the tissue-engineered valves and the integration of anticoagulation properties into the valves. Such is the case with advancements in prosthetic technology where not only optimal operations that bring better patients’ outcomes are considered but also problems associated with the durability and thrombogenicity of existing prosthetic options are solved, making them the top choice in healthcare organizations.

Healthcare infrastructure improves and disposable incomes rise in regions

  • The world prosthetic heart valve market has many opportunities specifically for the development of newborn economies. With enhancements in the health care provision and upliftment in per capita income in developing markets such as Asia-Pacific and Latin America; there is a greater market need for innovative and sophisticated prosthetic heart valves. Healthcare organizations interested in grown their market share in those regions can benefit from steadily growing patient demand for cardiac procedures.

  • In addition, a synergy of efforts between the manufacturers of medical devices and healthcare service delivery organizations can act as an avenue to embrace local patients’ solutions based on areas of the globe. Increased and appropriate valve availability hence improved market coverage and unit utilization is likely to benefit patients while; Fieldname: Manufacturers.

Prosthetic Heart Valve Market Segment Analysis:

Prosthetic Heart Valve Market is Segmented on the basis of Heart type, Valve Type, End User, and Region.

By Heart Type, Mechanical Heart Valves segment is expected to dominate the market during the forecast period

  • The prosthetic heart valve market is segmented by heart type into three main categories: Currently there are three types of valves they include mechanical heart valves, bioprosthetic heart valves and transcatheter heart valves. Mechanical heart valves are produced from stainless or titanium or carbon and can be used for a long time; it is often prescribed to young patients with heart valve disease; these valves need the use of anticoagulation therapy for a lifetime to avoid the formation of blood clots. Biological valves are those sourced from animal tissues or cadavers are also more natural and carry little need to be anticoagulated besides post-surgery for sometimes indefinitely and are appropriate for elderly patients who may not tolerate the anticoagulations or those who cannot undergo the associated risks, but they may wear out more than mechanical ones. THVs are intended for minimal invasiveness, which means that they can be implanted using transcatheter techniques that eliminate the need for open heart surgery and are associated with much shorter recovery time and hospitalization, thereby increasing their use, particularly in increasingly prevalent populations of high-risk patients who cannot undergo surgery.

By Valve Type, Aortic Valve segment expected to held the largest share

  • The prosthetic heart valve market is also divided according to the valve kind that comprises of aortic valves, mitral valves, and other valves. The aortic valve is replaced most frequently because of diseases such as aortic stenosis or regurgitation in which the valve either will not open, or closing, allowing inadequate blood flow through the heart and increased amount of work for the heart muscle. Mitral valves are replaced in cases of mitral regurgitation or stenosis which leads to faulty shutting of blood ???? which leads to weakness, shortness of breath etc. Other types of valves that could be used are the pulmonary valve and the tricuspid valve, necessary though less often used in operations concerning the heart. These segments of valves involve differences with regards to surgical management, patient selection and long-term follow up; thus knowledge of these segments is important both for those in the healthcare profession and prosthetic heart valve market.

Prosthetic Heart Valve Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

  • North America is holding the largest market share for the Prosthetic Heart Valve Market in the current scenario because of the well-developed healthcare industry and a relatively higher per capita healthcare expenditure coupled with leading market players. The region has strong emphasis on emphases on research and development, and the development of products that continue to adapt to the requirements of patient and healthcare consumers. In the same regard, clear and favorable requisite guidelines for the approval of new devices has ensured that North America proves to be an industry leader in the market.

  • Furthermore, the rate of incidents of heart diseases in North America region is high and people are in need of surgeries and prosthetic limbs. They observed that the population is aging leading to the need for cardiovascular diseases treatment due to broader risk factors. Hence, the constant flow of investments in healthcare structures and improvement of technologies in the region makes North America one of the leaders of the Prosthetic Heart Valve Market.

Active Key Players in the Prosthetic Heart Valve Market:

  • Medtronic (USA)

  • Edwards Lifesciences (USA)
  • Abbott Laboratories (USA)
  • Boston Scientific Corporation (USA)
  • St. Jude Medical (USA)
  • Sorin Group (Italy)
  • CryoLife, Inc. (USA)
  • JenaValve Technology (Germany)
  • SYMPLICITY (USA)
  • AtriCure, Inc. (USA)
  • Other Active Players

Prosthetic Heart Valve Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 10.00 Billion

Forecast Period 2024-32 CAGR:

 12.90%

Market Size in 2032:

USD 29.81 Billion

Segments Covered:

By Heart Type
  • Mechanical Heart Valves
  • Bioprosthetic Heart Valves
  • Transcatheter Heart Valves

By Valve Type
  • Aortic Valve
  • Mitral Valve
  • Others

By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Region
  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:
  • Increasing Prevalence of Heart Diseases

Key Market Restraints:
  • Risks Associated with Surgical Procedures

Key Opportunities:
  • Emerging Markets with Expanding Healthcare Infrastructure

Companies Covered in the report:
  •  Medtronic (USA), Edwards Lifesciences (USA), Abbott Laboratories (USA), Boston Scientific Corporation (USA), St. Jude Medical (USA), Sorin Group (Italy), CryoLife, Inc. (USA), JenaValve Technology (Germany), SYMPLICITY (USA), AtriCure, Inc. (USA)and Other Active Players.

Frequently Asked Questions :

What would be the forecast period in the Prosthetic Heart Valve Market research report?
The forecast period in the Prosthetic Heart Valve Market research report is 2024-2032.
Who are the key players in the Prosthetic Heart Valve Market?
Medtronic (USA), Edwards Lifesciences (USA), Abbott Laboratories (USA), Boston Scientific Corporation (USA), St. Jude Medical (USA), Sorin Group (Italy), CryoLife, Inc. (USA), JenaValve Technology (Germany), SYMPLICITY (USA), AtriCure, Inc. (USA), Other Active Players.
What are the segments of the Prosthetic Heart Valve Market?
The Prosthetic Heart Valve Market is segmented into by Heart Type (Mechanical Heart Valves, Bioprosthetic Heart Valves, Transcatheter Heart Valves), By Valve Type (Aortic Valve, Mitral Valve, Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics). By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Russia, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
What is the Prosthetic Heart Valve Market?
The Prosthetic Heart Valve Market means the segment of an economy that deals with the production and distribution of man-made valves to restore the functionality of non-functional human heart valves for valvular heart disease patients. Such prosthetic devices are significant tools in the provision of normal circulation to the heart; hence improving the life of the patients. The market includes different kinds of valve such as mechanical and bioprosthetic valve that satisfies the various need and demand of the patients.
How big is the Prosthetic Heart Valve Market?
Prosthetic Heart Valve Market Size Was Valued at USD 10.00 Billion in 2023, and is Projected to Reach USD 29.81 Billion by 2032, Growing at a CAGR of 12.90% From 2024-2032.
Request Sample

Related Reports

Services Designed to Meet Your Priorities

Understand your customers' needs so can deliver better services and experiences.

Show more

Subscribe to our Newsletter

Stay in touch with us to get latest news and discount coupons.